{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:29:17Z","timestamp":1785025757110,"version":"3.55.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 EB033516"],"award-info":[{"award-number":["R21 EB033516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K00AG068440-03"],"award-info":[{"award-number":["K00AG068440-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB031771"],"award-info":[{"award-number":["P41EB031771"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG041633"],"award-info":[{"award-number":["R01AG041633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00AG062230"],"award-info":[{"award-number":["R00AG062230"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1MH086881"],"award-info":[{"award-number":["RO1MH086881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG059390"],"award-info":[{"award-number":["R01AG059390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG038893"],"award-info":[{"award-number":["R01AG038893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001079"],"award-info":[{"award-number":["UL1TR001079"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neurobiolaging.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T12:09:23Z","timestamp":1718885363000},"page":"27-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy"],"prefix":"10.1016","volume":"142","author":[{"given":"Christopher W.","family":"Davies-Jenkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford I.","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Hupfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge J.","family":"Z\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie-Marie","family":"Leoutsakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Kraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenn S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Oeltzschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(00)02246-7","article-title":"Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer\u2019s disease","volume":"355","author":"Adalsteinsson","year":"2000","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.euroneuro.2015.04.016","article-title":"Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations","volume":"25","author":"Arnone","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib4","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/jmri.24665","article-title":"Decreased \u03b3-aminobutyric acid levels in the parietal region of patients with Alzheimer\u2019s disease","volume":"41","author":"Bai","year":"2015","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer\u2019s Disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting Linear Mixed-Effects Models Using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005\u20132010","volume":"71","author":"Beach","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1037\/1040-3590.8.2.145","article-title":"Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity","volume":"8","author":"Benedict","year":"1996","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jmri.20214","article-title":"Neurochemistry of late-life major depression: a pilot two-dimensional MR spectroscopic study","volume":"20","author":"Binesh","year":"2004","journal-title":"J. Magn. Reson. Imaging JMRI"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41586-020-2314-9","article-title":"Variability in the analysis of a single neuroimaging dataset by many teams","volume":"582","author":"Botvinik-Nezer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib12","author":"Botvinik-Nezer","year":"2024","journal-title":"Anal. Reprod. Ment. Health Res.: Chall. Solut."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib13","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.neurobiolaging.2008.09.012","article-title":"Plaque and tangle imaging and cognition in normal aging and Alzheimer\u2019s disease","volume":"31","author":"Braskie","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib14","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib15","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, Structural, and Functional Characterization of Alzheimer\u2019s Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib17","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.2967\/jnumed.121.263195","article-title":"The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review","volume":"63","author":"Chapleau","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pscychresns.2009.01.003","article-title":"Proton magnetic resonance spectroscopy of late-life major depressive disorder","volume":"172","author":"Chen","year":"2009","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib19","article-title":"Lower Posterior Cingulate N-acetylaspartate to Creatine Level in Early Detection of Biologically Defined Alzheimer\u2019s Disease","volume":"12","author":"Chen","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J. Alzheimers Dis","volume":"34","author":"Chien","year":"2013","journal-title":"JAD"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neubiorev.2019.01.003","article-title":"Neurochemical changes in the aging brain: A systematic review","volume":"98","author":"Cleeland","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib22","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41467-022-31347-8","article-title":"A guided multiverse study of neuroimaging analyses","volume":"13","author":"Dafflon","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00259-013-2682-6","article-title":"PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB","volume":"41","author":"de Paula Faria","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/appi.ajp.2016.16030319","article-title":"No Association of Lower Hippocampal Volume With Alzheimer\u2019s Disease Pathology in Late-Life Depression","volume":"174","author":"De Winter","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2004.02.079","article-title":"Magnetic resonance spectroscopic analysis of Alzheimer\u2019s disease mouse brain that express mutant human APP shows altered neurochemical profile","volume":"1012","author":"Dedeoglu","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib26","article-title":"A Traveler\u2019s Guide to the Multiverse: Promises, Pitfalls, and a Framework for the Evaluation of Analytic Decisions","volume":"4","author":"Del Giudice","year":"2021","journal-title":"Adv. Methods Pract. Psychol. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib27","author":"Delis","year":"2012","journal-title":"Delis-Kaplan Exec. Funct. Syst."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib28","series-title":"California verbal learning test, adult version (CVLT-II)","author":"Delis","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib29","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer\u2019s Disease Brain Is Associated with Mitochondrial Dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and Alzheimer\u2019s disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2013","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jad.2015.03.007","article-title":"Oxidative stress and depressive symptoms in older adults: A magnetic resonance spectroscopy study","volume":"180","author":"Duffy","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib33","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.npp.1300553","article-title":"Brain Metabolites and Cognitive Function among Older Depressed and Healthy Individuals Using 2D MR Spectroscopy","volume":"29","author":"Elderkin-Thompson","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib34","first-page":"175","article-title":"Volumetric analysis on MRI and PET images for the early diagnosis of Alzheimer\u2019s disease.","volume":"34","author":"Esposito","year":"2011","journal-title":"Nuovo Cim. Della Soc. Ital. Fis. C."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1533317511421780","article-title":"Brain Glutamate Levels Are Decreased in Alzheimer\u2019s Disease: A Magnetic Resonance Spectroscopy Study","volume":"26","author":"Fayed","year":"2011","journal-title":"Am. J. Alzheimers Dis. Dement. \u00ae"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib36","article-title":"Structured clinical interview for DSM-IV axis I disorders","author":"First","year":"1997","journal-title":"N. Y. State Psychiatr. Inst."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib38","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.3174\/ajnr.A3944","article-title":"Various MRS application tools for Alzheimer disease and mild cognitive impairment. AJNR","volume":"35","author":"Gao","year":"2014","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuroimage.2013.04.012","article-title":"Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels","volume":"78","author":"Gao","year":"2013","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.rx.2010.04.005","article-title":"[Regional effects of age and sex in magnetic resonance spectroscopy]","volume":"52","author":"Garc\u00eda Santos","year":"2010","journal-title":"Radiologia"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119740","article-title":"Neurometabolic timecourse of healthy aging","volume":"264","author":"Gong","year":"2022","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1006\/nimg.2000.0557","article-title":"Chemical Heterogeneity of the Living Human Brain: A Proton MR Spectroscopy Study on the Effects of Sex, Age, and Brain Region","volume":"11","author":"Grachev","year":"2000","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-510X(98)00095-1","article-title":"Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases","volume":"158","author":"Gu","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neurobiolaging.2007.07.005","article-title":"A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging","volume":"30","author":"Haga","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/nbm.2875","article-title":"Imaging of glutamate neurotransmitter alterations in Alzheimer\u2019s disease","volume":"26","author":"Haris","year":"2013","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00001756-200201210-00041","article-title":"Proton MR spectroscopic study at 3 Tesla on glutamate\/glutamine in Alzheimer\u2019s disease","volume":"13","author":"Hattori","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib47","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3233\/JAD-215431","article-title":"Frontal Metabolites and Alzheimer\u2019s Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment","volume":"87","author":"Hone-Blanchet","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib48","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1007\/s00330-016-4669-8","article-title":"Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment","volume":"27","author":"Huang","year":"2017","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mrm.29895","article-title":"sLASER and PRESS perform similarly at revealing metabolite-age correlations at 3 T","volume":"91","author":"Hui","year":"2024","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib50","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1093\/cercor\/bhab107","article-title":"In Vivo Brain Glutathione is Higher in Older Age and Correlates with Mobility","volume":"31","author":"Hupfeld","year":"2021","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib51","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","article-title":"Strategies to Improve Neuroreceptor Parameter Estimation by Linear Regression Analysis","volume":"22","author":"Ichise","year":"2002","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib52","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0022-510X(94)90077-9","article-title":"N-Acetylaspartate and N-acetylaspartylglutamate levels in Alzheimer\u2019s disease post-mortem brain tissue","volume":"127","author":"Jaarsma","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","article-title":"Cerebral amyloid PET imaging in Alzheimer\u2019s disease","volume":"126","author":"Jack","year":"2013","journal-title":"Acta Neuropathol. (Berl. )"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib56","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.25212","article-title":"Neurochemical abnormalities in premanifest and early spinocerebellar ataxias","volume":"83","author":"Joers","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jmri.23800","article-title":"Proton MRS in mild cognitive impairment","volume":"37","author":"Kantarci","year":"2013","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib58","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.neurobiolaging.2006.06.018","article-title":"Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer\u2019s disease","volume":"28","author":"Kantarci","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e31829a3329","article-title":"MRI and MRS predictors of mild cognitive impairment in a population-based sample","volume":"81","author":"Kantarci","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neurobiolaging.2021.12.010","article-title":"1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults","volume":"112","author":"Kara","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib61","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11055-019-00858-1","article-title":"Cerebral Metabolism in Patients with Cognitive Disorders: a Combined Magnetic Resonance Spectroscopy and Positron Emission Tomography Study","volume":"49","author":"Khomenko","year":"2019","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib62","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mrm.25568","article-title":"The trouble with quality filtering based on relative Cram\u00e9r-Rao lower bounds","volume":"75","author":"Kreis","year":"2016","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib64","first-page":"22","article-title":"Analysis of the brain proton magnetic resonance spectroscopy \u2013 differences between normal grey and white matter","volume":"75","author":"Krukowski","year":"2010","journal-title":"Pol. J. Radiol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib65","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archgenpsychiatry.2011.122","article-title":"Protein Binding in Patients With Late-Life Depression","volume":"68","author":"Kumar","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib66","series-title":"Brain Edema XIV, Acta Neurochirurgica Supplementum","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-211-98811-4_32","article-title":"Metabolic Changes in Rat Brain Following Intracerebroventricular Injections of Streptozotocin: A Model of Sporadic Alzheimer\u2019s Disease","author":"Labak","year":"2010"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib67","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/jnnp-2014-308577","article-title":"CSF lactate levels, \u03c4 proteins, cognitive decline: a dynamic relationship in Alzheimer\u2019s disease","volume":"86","author":"Liguori","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4484","article-title":"Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): Experts\u2019 consensus recommendations","volume":"34","author":"Lin","year":"2021","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib69","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.738971","article-title":"Meta-Analysis of Neurochemical Changes Estimated via Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"13","author":"Liu","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib71","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3233\/JAD-2010-091654","article-title":"Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. J. Alzheimers Dis","volume":"21","author":"Liu","year":"2010","journal-title":"JAD"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib72","doi-asserted-by":"crossref","first-page":"772","DOI":"10.21105\/joss.00772","article-title":"ggeffects: Tidy Data Frames of Marginal Effects from Regression Models","volume":"3","author":"L\u00fcdecke","year":"2018","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neubiorev.2011.05.014","article-title":"Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings","volume":"36","author":"Luykx","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib74","first-page":"757","article-title":"Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer\u2019s Disease Neuroimaging Initiative Depression Project","volume":"89","author":"Mackin","year":"2021","journal-title":"Biol. Psychiatry, Late-Life Depress Dement."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib75","series-title":"Brain Imaging in Behavioral Neuroscience, Current Topics in Behavioral Neurosciences","first-page":"199","article-title":"MR Spectroscopic Studies of the Brain in Psychiatric Disorders","author":"Maddock","year":"2012"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2011.11.047","article-title":"Brain oxidative stress: Detection and mapping of anti-oxidant marker \u2018Glutathione\u2019 in different brain regions of healthy male\/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy","volume":"417","author":"Mandal","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib77","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1073\/pnas.0505513102","article-title":"Monitoring disease progression in transgenic mouse models of Alzheimer\u2019s disease with proton magnetic resonance spectroscopy","volume":"102","author":"Marjanska","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib78","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-180861","article-title":"Distinctive Neurochemistry in Alzheimer\u2019s Disease via 7 T In Vivo Magnetic Resonance Spectroscopy","volume":"68","author":"Marja\u0144ska","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib79","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroscience.2013.11.052","article-title":"Treatment effects in a transgenic mouse model of Alzheimer\u2019s disease: a magnetic resonance spectroscopy study after passive immunization","volume":"259","author":"Marja\u0144ska","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib80","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1093\/brain\/awab222","article-title":"Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer\u2019s disease","volume":"144","author":"Matthews","year":"2021","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.wnr.0000203353.52622.05","article-title":"Magnetic resonance spectroscopic study of Alzheimer\u2019s disease and frontotemporal dementia\/Pick complex","volume":"17","author":"Mihara","year":"2006","journal-title":"NeuroReport"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib82","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in Patients With Mild Cognitive Impairment Increases the Risk of Developing Dementia of Alzheimer Type: A Prospective Cohort Study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib83","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (cdr): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib84","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib85","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer\u2019s Disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib86","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/acn3.530","article-title":"Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer\u2019s brain","volume":"5","author":"Mullins","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neurobiolaging.2018.09.027","article-title":"Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla","volume":"73","author":"Oeltzschner","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108827","article-title":"Osprey: Open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data","volume":"343","author":"Oeltzschner","year":"2020","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib89","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s11064-017-2181-4","article-title":"NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer\u2019s, and Ethanol Intoxication","volume":"42","author":"Olszewski","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/alzrt195","article-title":"Amyloid imaging in clinical trials","volume":"5","author":"Ossenkoppele","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4236","article-title":"Advanced single voxel 1H magnetic resonance spectroscopy techniques in humans: Experts\u2019 consensus recommendations","volume":"34","author":"\u00d6z","year":"2021","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib92","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.54.3.735","article-title":"Cerebrospinal fluid pyruvate levels in Alzheimer\u2019s disease and vascular dementia","volume":"54","author":"Parnetti","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02815236","article-title":"N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer\u2019s diseases","volume":"31","author":"Passani","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib94","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib95","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62575","article-title":"The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies","volume":"10","author":"Porges","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mrm.1910390110","article-title":"Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS","volume":"39","author":"Pouwels","year":"1998","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib97","author":"Prince","year":"2015","journal-title":"World Alzheimer Rep. 2015 - Glob. Impact Dement.: Anal. Preval., Incid., Cost. Trends"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib99","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib100","series-title":"R: A language and environment for statistical computing. R Foundation for Statistical Computing","author":"R Core Team","year":"2016"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/2009\/609839","article-title":"Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo","volume":"21","author":"Rabinovici","year":"2009","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/nbdi.1999.0273","article-title":"Oxidative insults are associated with apolipoprotein E genotype in Alzheimer\u2019s disease brain","volume":"7","author":"Ramassamy","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib103","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2014.07.030","article-title":"Posterior cingulate gamma-aminobutyric acid and glutamate\/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype","volume":"36","author":"Riese","year":"2015","journal-title":"Neurobiol. AGING"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11065-009-9118-x","article-title":"Beta-Amyloid Deposition and the Aging Brain","volume":"19","author":"Rodrigue","year":"2009","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib106","unstructured":"RStudio Team, 2020. RStudio: Integrated development environment for R (manual). Boston, MA."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib107","first-page":"1439","article-title":"Reference Values for Long Echo Time MR Spectroscopy in Healthy Adults","volume":"26","author":"Safriel","year":"2005","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib108","article-title":"Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old age","volume":"16","author":"Schreiner","year":"2024","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib109","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.25202","article-title":"Positron emission tomography\u2013guided magnetic resonance spectroscopy in Alzheimer disease","volume":"83","author":"Sheikh-Bahaei","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2007.04.017","article-title":"A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer\u2019s disease","volume":"260","author":"Shinno","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1522-2594(199907)42:1<24::AID-MRM5>3.0.CO;2-3","article-title":"1H chemical shift imaging of the human brain at age 60\u201390 years reveals metabolic differences between women and men","volume":"42","author":"Sijens","year":"1999","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib112","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41562-020-0912-z","article-title":"Specification curve analysis","volume":"4","author":"Simonsohn","year":"2020","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nbd.2017.05.007","article-title":"Molecular imaging of serotonin degeneration in mild cognitive impairment","volume":"105","author":"Smith","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib114","unstructured":"Smith G.S.Kuwabara H.Nandi, A.Gould, N.F.Nassery, N.Savonenko, A.Joo, J.H.Kraut, M.Brasic, J.Holt, D.P.Hall, A.W. Mathews, W.B.Dannals, R.F.Avramopoulos, D.Workman , C.I.2021Molecular imaging of beta-amyloid deposition in late-life depressionNeurobiol. Aging101859310.1016\/j.neurobiolaging.2021.01.002."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jad.2020.10.011","article-title":"Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T","volume":"279","author":"Smith","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01539-9","article-title":"Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares","volume":"11","author":"Smith","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib117","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","article-title":"Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology","volume":"76","author":"Smith","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib118","first-page":"2195","article-title":"The second generation HRRT - a multi-centre scanner performance investigation","volume":"2005","author":"Sossi","year":"2005"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib119","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac135","article-title":"Astrocytic function is associated with both amyloid-\u03b2 and tau pathology in non-demented APOE \u03f54 carriers","volume":"4","author":"Spotorno","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroimage.2013.01.009","article-title":"Magnetic Resonance Spectroscopy as a tool to study the role of GABA in motor-cortical plasticity","volume":"86","author":"Stagg","year":"2014","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib121","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.22320","article-title":"Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4\u2032-methylaminophenyl)- 6-hydroxybenzothiazole","volume":"69","author":"Stankoff","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib122","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/1745691616658637","article-title":"Increasing Transparency Through a Multiverse Analysis","volume":"11","author":"Steegen","year":"2016","journal-title":"Perspect. Psychol. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JAD-2012-111922","article-title":"Late-Life Depression as a Risk Factor for Mild Cognitive Impairment or Alzheimer\u2019s Disease in 30 US Alzheimer\u2019s Disease Centers","volume":"31","author":"Steenland","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib124","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac016","article-title":"Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment","volume":"4","author":"Stevens","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G","article-title":"In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time","volume":"41","author":"Tk\u00e1\u010d","year":"1999","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib126","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3233\/JAD-140405","article-title":"Depression in Mild Cognitive Impairment is associated with Progression to Alzheimer\u2019s Disease: A Longitudinal Study","volume":"42","author":"Van der Mussele","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib127","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pscychresns.2008.07.001","article-title":"Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression","volume":"172","author":"Venkatraman","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib128","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1212\/WNL.0000000000002672","article-title":"Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease","volume":"86","author":"Voevodskaya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib129","first-page":"MT105","article-title":"N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI)","volume":"17","author":"Walecki","year":"2011","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib130","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib131","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3233\/JAD-170450","article-title":"Decreased N-Acetyl Aspartate\/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer\u2019s Disease: A 7-Year Follow-Up Study","volume":"60","author":"Waragai","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/610605","article-title":"Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment","volume":"2015","author":"Weaver","year":"2015","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib133","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00259-013-2627-0","article-title":"Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45\/Amyvid) positron emission tomography","volume":"41","author":"Wu","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib134","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20131685","article-title":"Neuronal activity regulates extracellular tau in vivo","volume":"211","author":"Yamada","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jon.12454","article-title":"Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study","volume":"27","author":"Zeydan","year":"2017","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.neurobiolaging.2024.06.003_bib136","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroimage.2006.05.063","article-title":"Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer\u2019s disease","volume":"33","author":"Ziolko","year":"2006","journal-title":"NeuroImage"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024001210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024001210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:51:48Z","timestamp":1777528308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458024001210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":136,"alternative-id":["S0197458024001210"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.06.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}